2020
DOI: 10.1016/j.chroma.2020.461055
|View full text |Cite
|
Sign up to set email alerts
|

Optimization study on periodic counter-current chromatography integrated in a monoclonal antibody downstream process

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
35
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 42 publications
(35 citation statements)
references
References 24 publications
0
35
0
Order By: Relevance
“…The setup was an adaptation of that used previously (Gomis‐Fons et al, 2020); the main difference being the inclusion of continuous virus inactivation with solvent/detergent before the capture step (see Figure 2). In this setup, the capture columns used in the PCC operation were loaded directly from the virus inactivation reactor (red line in Figure 2).…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…The setup was an adaptation of that used previously (Gomis‐Fons et al, 2020); the main difference being the inclusion of continuous virus inactivation with solvent/detergent before the capture step (see Figure 2). In this setup, the capture columns used in the PCC operation were loaded directly from the virus inactivation reactor (red line in Figure 2).…”
Section: Methodsmentioning
confidence: 99%
“…The cycle time must be equal to, or longer than, the recovery time, based on the continuity constraint (Godawat et al, 2012). In this case, the capture and polishing steps were run simultaneously, and therefore the minimum cycle time was determined by the longest recovery time of these steps, as described previously (Gomis‐Fons et al, 2020). By determining the flow rate in this way, at least the same yield and resin utilization as we obtained previously could be obtained at the minimum cycle time (Löfgren et al, 2018).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The CCC methods are the most widely used in the field of pharmaceutical and natural product analytical and preparative-scale separations (alkaloids, peptides, drugs, chiral compounds, etc.) [ 17 , 27 , 28 , 29 , 30 , 38 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 ,…”
Section: Introductionmentioning
confidence: 99%